1. Home
  2. NC vs VNDA Comparison

NC vs VNDA Comparison

Compare NC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

N/A

Current Price

$35.79

Market Cap

300.7M

Sector

Energy

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$4.57

Market Cap

301.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NC
VNDA
Founded
1913
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.7M
301.1M
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
NC
VNDA
Price
$35.79
$4.57
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $11.75
AVG Volume (30 Days)
19.9K
★ 778.6K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
★ 2.87%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.04
N/A
Revenue
$104,778,000.00
★ $216,105,000.00
Revenue This Year
N/A
$15.16
Revenue Next Year
N/A
$35.50
P/E Ratio
$35.13
★ N/A
Revenue Growth
N/A
★ 8.72
52 Week Low
$35.45
$4.27
52 Week High
$59.42
$9.91

Technical Indicators

Market Signals
Indicator
NC
VNDA
Relative Strength Index (RSI) 32.27 33.10
Support Level $35.74 $4.45
Resistance Level $38.89 $5.37
Average True Range (ATR) 1.04 0.17
MACD 0.11 -0.04
Stochastic Oscillator 9.88 20.92

Price Performance

Historical Comparison
NC
VNDA

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments: Utility Coal Mining, Contract Mining, and Minerals and Royalties. The Utility Coal Mining segment, operated by North American Coal, manages surface coal mines that are exclusive, long-term fuel providers for power generation companies. The Contract Mining segment, operated by North American Mining, is a provider of a broad range of specialized, long-term contract mining services. The Minerals and Royalties segment, which includes the Catapult Mineral Partners (Catapult) business, acquires and promotes the development of mineral and royalty interests and other related investments.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: